(R/S)-Alicaforsen is the racemate of Alicaforsen composed of R and S configurations. Alicaforsen is a 20-base antisense oligonucleotide inhibiting ICAM-1 production, which is an important adhesion molecule involved in leukocyte migration and
(R/S)-Alicaforsen is the racemate of Alicaforsen composed of R and S configurations. Alicaforsen is a 20-base antisense oligonucleotide inhibiting ICAM-1 production, which is an important adhesion molecule involved in leukocyte migration and
(R/S)-Alicaforsen is the racemate of Alicaforsen composed of R and S configurations. Alicaforsen is a 20-base antisense oligonucleotide inhibiting ICAM-1 production, which is an important adhesion molecule involved in leukocyte migration and
(R/S)-Alicaforsen is the racemate of Alicaforsen composed of R and S configurations. Alicaforsen is a 20-base antisense oligonucleotide inhibiting ICAM-1 production, which is an important adhesion molecule involved in leukocyte migration and
(R/S)-Alicaforsen is the racemate of Alicaforsen composed of R and S configurations. Alicaforsen is a 20-base antisense oligonucleotide inhibiting ICAM-1 production, which is an important adhesion molecule involved in leukocyte migration and
(R/S)-Alicaforsen is the racemate of Alicaforsen composed of R and S configurations. Alicaforsen is a 20-base antisense oligonucleotide inhibiting ICAM-1 production, which is an important adhesion molecule involved in leukocyte migration and
AT-1002 TFA, a 6-mer synthetic peptide , is a tight junction regulator and absorption enhancer .Appearance:SolidIn Vitro:AT-1002, a 6-mer synthetic peptide, belongs to an emerging novel class of compounds that reversibly increase paracellular
AT-1002 TFA, a 6-mer synthetic peptide , is a tight junction regulator and absorption enhancer .Appearance:SolidIn Vitro:AT-1002, a 6-mer synthetic peptide, belongs to an emerging novel class of compounds that reversibly increase paracellular
AT-1002 TFA, a 6-mer synthetic peptide , is a tight junction regulator and absorption enhancer .Appearance:SolidIn Vitro:AT-1002, a 6-mer synthetic peptide, belongs to an emerging novel class of compounds that reversibly increase paracellular
AT-1002 TFA, a 6-mer synthetic peptide , is a tight junction regulator and absorption enhancer .Appearance:SolidIn Vitro:AT-1002, a 6-mer synthetic peptide, belongs to an emerging novel class of compounds that reversibly increase paracellular
AT-1002 TFA, a 6-mer synthetic peptide , is a tight junction regulator and absorption enhancer .Appearance:SolidIn Vitro:AT-1002, a 6-mer synthetic peptide, belongs to an emerging novel class of compounds that reversibly increase paracellular
AT-1002 TFA, a 6-mer synthetic peptide , is a tight junction regulator and absorption enhancer .Appearance:SolidIn Vitro:AT-1002, a 6-mer synthetic peptide, belongs to an emerging novel class of compounds that reversibly increase paracellular
AT-1002 TFA, a 6-mer synthetic peptide , is a tight junction regulator and absorption enhancer .Appearance:SolidIn Vitro:AT-1002, a 6-mer synthetic peptide, belongs to an emerging novel class of compounds that reversibly increase paracellular
AT-1002 TFA, a 6-mer synthetic peptide , is a tight junction regulator and absorption enhancer .Appearance:SolidIn Vitro:AT-1002, a 6-mer synthetic peptide, belongs to an emerging novel class of compounds that reversibly increase paracellular
AT-1002 TFA, a 6-mer synthetic peptide , is a tight junction regulator and absorption enhancer .In Vitro:AT-1002, a 6-mer synthetic peptide, belongs to an emerging novel class of compounds that reversibly increase paracellular transport of
AT-1002 TFA, a 6-mer synthetic peptide , is a tight junction regulator and absorption enhancer .In Vitro:AT-1002, a 6-mer synthetic peptide, belongs to an emerging novel class of compounds that reversibly increase paracellular transport of
ATM-3507 is a potent tropomyosin inhibitor with IC 50 s from 3.83-6.84 μM in human melanoma cell lines.In VitroThe cell lines differ in their relative expression of Tpm3.1 as well as in the expression of other isoforms. After determing the IC 50
ATM-3507 is a potent tropomyosin inhibitor with IC 50 s from 3.83-6.84 μM in human melanoma cell lines.In VitroThe cell lines differ in their relative expression of Tpm3.1 as well as in the expression of other isoforms. After determing the IC 50
ATM-3507 is a potent tropomyosin inhibitor with IC 50 s from 3.83-6.84 μM in human melanoma cell lines.In VitroThe cell lines differ in their relative expression of Tpm3.1 as well as in the expression of other isoforms. After determing the IC 50
ATM-3507 is a potent tropomyosin inhibitor with IC 50 s from 3.83-6.84 μM in human melanoma cell lines.In VitroThe cell lines differ in their relative expression of Tpm3.1 as well as in the expression of other isoforms. After determing the IC 50
ATM-3507 is a potent tropomyosin inhibitor with IC 50 s from 3.83-6.84 μM in human melanoma cell lines.In VitroThe cell lines differ in their relative expression of Tpm3.1 as well as in the expression of other isoforms. After determing the IC 50
ATM-3507 is a potent tropomyosin inhibitor with IC 50 s from 3.83-6.84 μM in human melanoma cell lines.In VitroThe cell lines differ in their relative expression of Tpm3.1 as well as in the expression of other isoforms. After determing the IC 50
ATN-161 trifluoroacetate salt is a novel integrin α5β1 antagonist, which inhibits angiogenesis and growth of liver metastases in a murine model.In VitroThe combination of ATN-161 plus 5-FU significantly reduces tumor cell proliferation compared to
ATN-161 trifluoroacetate salt is a novel integrin α5β1 antagonist, which inhibits angiogenesis and growth of liver metastases in a murine model.In VitroThe combination of ATN-161 plus 5-FU significantly reduces tumor cell proliferation compared to